Founded by Dr Mark Kotter and Florian Schuster, bit.bio is an award-winning human synthetic biology enterprise.
bit.bio’s mission is coding cells for health.
To do so, we apply the principles of computation to biology.
We have aligned our purpose to use our innovative technology to tackle social and environmental challenges by providing leadership on social responsibility and sustainability.
Our current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. This has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease.
A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies.
To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modelling, and cell therapy.
Collaboration is at the heart of bit.bio. We are empirical, ambitious, trustworthy and driven by a common purpose.
Dr Mark Kotter, Founder CEO